cbdMD Backs Bipartisan Bill to Avert November Hemp Industry Shakeup
Event summary
- cbdMD supports the bipartisan Lawful Hemp Protection Act introduced July 21, 2026 to prevent a November 12, 2026 federal hemp definition change that could remove many full-spectrum CBD products from the market.
- The bill proposes FDA oversight with mandatory third-party testing, transparent labeling, and a 21-and-over age requirement for hemp-derived products.
- cbdMD endorses the Administration's call to update the hemp definition through pending budget legislation before the November deadline.
The big picture
The Lawful Hemp Protection Act represents a critical effort to stabilize the U.S. hemp industry amid impending federal regulatory changes. The bipartisan support signals growing consensus for responsible regulation over prohibition, which could shape the future of hemp-derived wellness products and consumer access.
What we're watching
- Regulatory Timeline
- Whether Congress can pass the Lawful Hemp Protection Act or update the hemp definition through budget legislation before the November 12, 2026 deadline.
- Industry Impact
- How a narrowing federal hemp definition would affect cbdMD and other hemp-derived product manufacturers if no legislative action is taken.
- Market Dynamics
- The pace at which the bipartisan bill gains traction as a potential long-term solution for the U.S. hemp industry's regulatory challenges.